FBK Legal Lawyers Registered the Resolution about Ranbaxy Issue
The International pharmaceutical Company Ranbaxy will place shares in closed subscription. The issuer intends to increase its capital by attracting investments of shareholders.
The lawyers of FBK Legal Corporate Practice acted as the Registrar for resolution about the issue. According to Dmitry Kudrin, the project manager, corporate law project manager, the issuer is entitled to place the shares during the year after the registration of resolution about the release.
“We will continue our work with the company and the next stage of the procedure will be the registration of report about the results of stock placing”, says Dmitry Kudrin.
Ranbaxy Laboratories Limited (Ranbaxy) is an international pharmaceutical company with the headquarters in India. The company bases its activities on the own scientific research. Ranbaxy produces a wide assortment of medicines and generics.
The lawyers of FBK Legal Corporate Practice acted as the Registrar for resolution about the issue. According to Dmitry Kudrin, the project manager, corporate law project manager, the issuer is entitled to place the shares during the year after the registration of resolution about the release.
“We will continue our work with the company and the next stage of the procedure will be the registration of report about the results of stock placing”, says Dmitry Kudrin.
Ranbaxy Laboratories Limited (Ranbaxy) is an international pharmaceutical company with the headquarters in India. The company bases its activities on the own scientific research. Ranbaxy produces a wide assortment of medicines and generics.
